
Empresas Banmédica (Banmédica S.A.)
Chile's largest private healthcare holding, combining isapres Banmédica and Vida Tres with a network of clinics, laboratories, and rescue services.
Company Type
private
Founded
1988
Headquarters
Las Condes, Santiago Metropolitan Region, Chile
Revenue
Not disclosed post-delisting (approximately US$1 billion transaction value, 2025)
Employees
approximately 10,000 (estimated, Chile and Colombia)
Primary Market
Latin America
Empresas Banmédica (Banmédica S.A.) Timeline
Shop Empresas Banmédica (Banmédica S.A.) Brands
Disclosure: We may earn commission from purchasesAbout Empresas Banmédica (Banmédica S.A.)
What is Empresas Banmédica?
It is Chile's largest private healthcare holding, combining isapres Banmédica and Vida Tres with a clinic network including Santa María and Dávila, the Vidaintegra outpatient chain, Help rescue, and Colombian operations.
Who owns Banmédica now?
UnitedHealth Group sold its controlling interest to a consortium of Brazil's Patria Investments and Chile's Linzor Capital Partners, agreed in November 2025 and fully approved by regulators on November 17, 2026.
Is Banmédica a public company?
No. Its shares were delisted from the Santiago Stock Exchange after UnitedHealth's 2018 acquisition, though Banmédica S.A. remains a registered bond issuer.
What is an isapre?
An isapre is a private health insurer in Chile. Workers can pay their mandatory health contribution to an isapre such as Banmédica instead of the public FONASA system.
Where is Banmédica headquartered?
At Apoquindo 3600, floor 12, in Las Condes, Santiago, Chile, with operations across Chile and Colombia.
How many people work at Banmédica?
The group employs approximately 10,000 people across its insurers, clinics, laboratories, and rescue services in Chile and Colombia.
History of Empresas Banmédica (Banmédica S.A.)
The business began inside the Chilean banking welfare system: from 1981, private health services were organized for employees affiliated with the Caja Bancaria de Pensiones, centered on preferential care in its own clinics. Banmédica was constituted as a public corporation in January 1988 and privatized the same year, its shares distributed among doctors (36 percent), employees (30 percent), and private investors (34 percent), with Clínica Dávila and Clínica Santa María as its founding assets.
The 1990s built the holding structure. Isapre Banmédica S.A. was created in 1990 to concentrate health insurance, and the Banrenta life insurer followed in 1991. The group merged with Inversiones Las Américas and Inversiones Clínicas, added stakes in Clínica Avansalud and Clínica Iquique, entered Peruvian pensions and Argentine social security ventures, and listed on the Santiago Stock Exchange from 1988.
The 2000s consolidated it into the country's largest integrated health group: two isapres, a flagship clinic network anchored by Santa María and Dávila, the Vidaintegra outpatient chain, Help rescue services, and Colombian expansion through Colmédica and clinic acquisitions.
UnitedHealth Group tendered for the company in December 2017 and completed the offer on January 28, 2018, taking control above 98 percent through Bordeaux Holding SpA in a deal valuing the group at roughly US$2.8 billion. The shares were subsequently delisted. Integration with UHG continued in technology and strategy terms through the early 2020s.
UHG's exit came in two acts. On November 29, 2025, UHG signed a Share Purchase Agreement to sell Bordeaux Holding SpA and CDC Holdings Colombia to Healthcare MX Holdings, a Patria Investments vehicle, for approximately US$1 billion, with Chile's Linzor Capital Partners joining the consortium. The deal required regulatory approvals in both countries; the final one, Colombia's clearance of the Aliansalud EPS transfer, was granted on November 17, 2026, closing out the approval process and marking the end of UHG's planned departure from South American markets.
Controversy, Regulation & Public Scrutiny
Banmédica operates inside Chile's most contested policy space. The isapre system is a standing subject of reform debate, with recurring legislative efforts to restructure or replace private health insurance, court cases over premium increases and coverage exclusions, and public scrutiny of the sector's handling of pre-existing conditions and price adjustments.
The ownership change itself drew antitrust review in both Chile and Colombia, where the Fiscalía Nacional Económica examined the consortium's structure before the final approvals arrived in November 2026. Beyond sector-wide debate, no singular Banmédica scandal defines the company as of November 2026.
Brands Owned by Empresas Banmédica (Banmédica S.A.)
Empresas Banmédica (Banmédica S.A.) owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Empresas Banmédica (Banmédica S.A.)
private · Founded 1988 · Las Condes, Santiago Metropolitan Region, Chile
1
brands
Empresas Banmédica (Banmédica S.A.) Ownership: Pros & Cons
Advantages
- +Unmatched vertical integration across insurance and provision
- +Flagship assets including Clínica Santa María and Dávila
- +Market leadership in the Chilean isapre system
- +New specialist healthcare owners aligned with the sector
Considerations
- -Structural regulatory risk to the isapre model
- -Approximately US$1 billion sale price implies value erosion since UHG's 2018 entry
- -Ownership transition demands strategy reset
- -Public and political pressure on private healthcare pricing
Frequently Asked Questions About Empresas Banmédica (Banmédica S.A.)
What is Empresas Banmédica?
It is Chile's largest private healthcare holding, combining isapres Banmédica and Vida Tres with a clinic network including Santa María and Dávila, the Vidaintegra outpatient chain, Help rescue, and Colombian operations.
Who owns Banmédica now?
UnitedHealth Group sold its controlling interest to a consortium of Brazil's Patria Investments and Chile's Linzor Capital Partners, agreed in November 2025 and fully approved by regulators on November 17, 2026.
Is Banmédica a public company?
No. Its shares were delisted from the Santiago Stock Exchange after UnitedHealth's 2018 acquisition, though Banmédica S.A. remains a registered bond issuer.
What is an isapre?
An isapre is a private health insurer in Chile. Workers can pay their mandatory health contribution to an isapre such as Banmédica instead of the public FONASA system.
Where is Banmédica headquartered?
At Apoquindo 3600, floor 12, in Las Condes, Santiago, Chile, with operations across Chile and Colombia.
How many people work at Banmédica?
The group employs approximately 10,000 people across its insurers, clinics, laboratories, and rescue services in Chile and Colombia.





